ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE)

PRESS RELEASE

published on 09/30/2025 at 19:30, 2 months 4 days ago

Renouvellement complet du Conseil d'administration Élection du Dr Markus Cappel en tant que Président du Conseil d'administration
Renouvellement complet du Conseil d'administration d'OSE Immunotherapeutics avec l'élection du Dr Markus Cappel comme Président. Assemblée Générale tenue à Paris. Nouveau Président se félicite de l'avenir prometteur de la Société

Assemblée Générale Conseil D'administration Renouvellement OSE Immunotherapeutics Dr Markus Cappel
PRESS RELEASE

published on 09/30/2025 at 19:30, 2 months 4 days ago

Full renewal of the Board of Directors Election of Dr. Markus Cappel as Chairman of the Board of Directors
OSE Immunotherapeutics renews Board of Directors and elects Dr. Markus Cappel as Chairman. Shareholders vote on key appointments

Board Of Directors Shareholders General Meeting OSE Immunotherapeutics Dr. Markus Cappel
BRIEF

published on 09/26/2025 at 07:05, 2 months 9 days ago

Strategic Partnership for Innovation in Immunotherapy

Strategic Partnership Oncology Industrial Support Immunotherapy Innovation Collaborative Research
BRIEF

published on 09/26/2025 at 07:05, 2 months 9 days ago

Partenariat stratégique pour l'innovation en immunothérapie

Partenariat Stratégique Oncologie Soutien Industriel Innovation Immunothérapie Recherche Collaborative
PRESS RELEASE

published on 09/26/2025 at 07:00, 2 months 9 days ago

OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
OSE Immunotherapeutics, Inserm Transfert, and Nantes University form a strategic partnership to advance immunotherapy for oncology, inflammation, and autoimmunity. The collaboration combines academic research and industrial expertise

Innovation Partnership Oncology Collaboration Immunotherapy
PRESS RELEASE

published on 09/26/2025 at 07:00, 2 months 9 days ago

OSE Immunotherapeutics, Inserm Transfert et Nantes Université annoncent un partenariat stratégique pour accélérer l’innovation en immunothérapie
Partenariat stratégique entre OSE Immunotherapeutics, Inserm Transfert et Nantes Université pour accélérer l'innovation en immunothérapie. Objectif : transformer découvertes académiques en thérapies de rupture

Partenariat Immunothérapie OSE Immunotherapeutics Inserm Transfert Nantes Université
BRIEF

published on 09/24/2025 at 08:05, 2 months 11 days ago

OSE Immunotherapeutics Corrects Voting Rights Error Before General Meeting

Voting Rights Shareholder Meeting Accusations Material Error Proxy Firms
BRIEF

published on 09/24/2025 at 08:05, 2 months 11 days ago

OSE Immunotherapeutics corrige une erreur de droit de vote avant l'assemblée générale

Droit De Vote Assemblée Des Actionnaires Erreur Matérielle Accusations Sociétés De Procuration
PRESS RELEASE

published on 09/24/2025 at 08:00, 2 months 11 days ago

Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital
OSE Immunotherapeutics corrects material error in total number of shares and voting rights, refutes accusations, and provides clarity on shareholder agreements and proxy advisory recommendations

Correction Proxy Advisory Shareholder Agreements OSE Immunotherapeutics Material Error
BRIEF

published on 09/23/2025 at 22:35, 2 months 11 days ago

OSE Immunotherapeutics répond à la décision du tribunal

Assemblée Générale Droits Des Actionnaires OSE Immunotherapeutics Tribunal De Commerce De Nantes Erreur Relative Aux Droits De Vote

Published on 12/05/2025 at 02:35, 6 hours 45 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 50 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 8 hours 20 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 15 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 20 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

Published on 12/05/2025 at 09:05, 14 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 19 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 19 minutes ago

SPECTRIS PLC - Removal
Published on 12/05/2025 at 09:00, 19 minutes ago

Official List Notice
Published on 12/05/2025 at 09:00, 19 minutes ago

Petershill Partners plc - Removal

View all EQS

Published on 12/05/2025 at 08:45, 35 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 35 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 37 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 5 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 20 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE

News